Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients

NCT01133067 | Completed Results DMC

• 1 other identifier: PROJECT NO 754
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

Does the routine clinical practice of follow up after primary treatment in lung cancer patients has any utility.

Conditions

Lung Cancer

Keywords

lung cancer; followup; physical follow up; telephonic followup

Outcome Measures

Primary Outcomes (1)

• Concurrence Between the Telephonic Interview and the Physician Assessment

  The Prevalence and bias adjusted Kappa (PABAK) score for concurrence between telephonic and physician assessment of disease status of each patient at each follow up visit was analysed.

  2 years

Secondary Outcomes (1)

• Cost Analysis

  2 years

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All curative lung cancer patients after there intial primary treatment who have already been given scheduled appointment shall be called telephonically every 3 months. A set of questions shall be asked to the patient in his /her vernacular during the telephonic interview.After the telephonic interview, the patients shall then report to the cancer care specialist at the Hospital for the due follow up visit.

You may qualify if:

• All patients of lung cancer treated with a radical aim (e.g surgery, Chemoradiation, surgery followed by adjuvant treatment or any other combination)
• Patients should have completed radical /adjuvant treatment, if any
• Patients of both SCLC and NSCLC
• Patients with at least two telephone numbers (landline/mobile/both)
• Patients willing to participate

You may not qualify if:

• All patients for palliative intention
• Patients with less than two contact telephone numbers -

Sponsors & Collaborators

• Tata Memorial Hospital: lead

Study Sites (1)

Tata Memorial Hospital

Mumbai, MS, 400012, India

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Results Point of Contact

• Title: Dr. J.P. Agarwal
• Organization: Dept. of Radiation Oncology, Tata Memorial Hospital

agarwaljp@tmc.gov.in

+91 22 24177000

Study Officials

• JP AGARWAL, MD

  Tata Memorial Hospital

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor Radiation Oncology

Study Record Dates

• First Submitted: May 27, 2010
• First Posted: May 28, 2010
• Study Start: July 1, 2010
• Primary Completion: July 1, 2016
• Study Completion: July 1, 2016
• Last Updated: August 7, 2018
• Results First Posted: August 7, 2018

Record last verified: 2017-11

Locations

IN (1)